Spera Pharma (Headquarters: Osaka, Japan; President and CEO: Keitaro Iwaki) will exhibit at 'Discovery & Development Europe 2026,' held from June 15 (Mon) to June 16 (Tue), 2026, at the Estrel Congress Center in Berlin, Germany. Atsushi Kaga from the company’s Pharmaceutical Research Laboratory will also participate as a speaker.
Event Overview 'Discovery & Development Europe 2026' Dates: June 15 (Mon) - June 16 (Tue), 2026 Venue: Estrel Congress Center (Berlin, Germany) Official Website: https://oxfordglobal.com/discovery-development/events/discovery-development-europe
Exhibits We will introduce cutting-edge technologies, including 3D ED / MicroED and Drug in Capsule (DIC).
Presentation Summary Title: Accurate solid form identification enabled by MicroED-based screening of crystal mixtures Date: June 16 (Tue) 11:15-11:40 Speakers: Main Speaker: Atsushi Kaga, Scientist, SPERA PHARMA Invited Speaker: Emillia Buchateiner, Application Scientist, Rigaku
FACT BOX
- Source: PR TIMES
- Category: Event
- Organizations: Rigaku
- Products / services: 3D ED / MicroED / Drug in Capsule (DIC)